Nash

Traditional Risk Factors for MASLD/MASH The Need to Diagnose MASH early Interrelation of MASLD and Cardiometabolic Disease From Awareness to Action

Table 1. Testosterone treatment vs no testosterone in adult men with MASH/MASLD INTRODUCTION Sex steroids modulate metabolic dysfunction-associated steatotic liver disease (MASLD) pathobiology. We hypothesized that testosterone treatment (TT) modulates progression of MASLD and performed a...

https://journey.ct.events/view/fd2ccdfc-2336-4f51-8019-a686ea745f44

https://www.prnewswire.com/news-releases/lipocine-announces-positive-lpcn-1144-nash-open-label-extension-study-results-301545697.html LPCN 1144 was well tolerated over 72-week exposure with no observed safety signals Liver injury markers were reduced and maintained with extended LPCN 1144...

https://www.sec.gov/Archives/edgar/data/1535955/000149315221026815/ex99-4.htm LPCN 1144 IMPROVES BODY COMPOSITION IN BIOPSY-CONFIRMED NASH PATIENTS Background: Non-alcoholic Steatohepatitis (NASH) is a common cause of liver disease and rapidly rising to be the leading indication for liver...